Julien J

Assessment tools for attention deficits in patients with stroke: a scoping review across components and recovery phases 1Department of Physical Therapy, Faculty of Health Sciences, Tokyo Metropolitan University, Tokyo, Japan 2Graduate School of Human Health Sciences, Tokyo Metropolitan University, Tokyo, Japan 3Faculty of Medical Sciences, Shonan University of Medical Sciences, Kanagawa, Japan 4Department of Physical Therapy, Hiroshima Cosmopolitan University, Hiroshima, Japan DOI...

There is an unmet clinical need to address residual cardiovascular risk beyond optimal lipid-lowering therapy (1). Even after low-density lipoprotein cholesterol (LDL-C) targets are met, a substantial risk of 70% of major adverse cardiovascular events (MACE) remains present (2). To address this residual risk, a molecularly defined status of cardiovascular health and disease (CVD) is needed.